Abstract
Background: Pneumothorax occurs when air enters the pleural cavity. Pneumothorax can be generally sub-divided into spontaneous and non-spontaneous subtypes. The most common examples of non-spontaneous pneumothorax include iatrogenic and traumatic.
Methods: Current studies provide good evidence of epidemiology of this condition. Similarly, there have been improvements in our understanding of underlying mechanisms of spontaneous pneumothorax. In the recent years new approaches to manage patients with pneumothorax have been proposed. These were led by development of new devices as well as better evidence from clinical studies on how to manage pneumothorax.
Conclusions: In this review we will discuss recent developments in our understanding in relation to in epidemiology, pathophysiology as well as management of pneumothorax.
Keywords: Cardio-respiratory, endobronchial, epidemiology, pathophysiology, pneumothorax, surgical management.
Current Respiratory Medicine Reviews
Title:State of the Art in Medical and Surgical Management of Pneumothorax
Volume: 13 Issue: 4
Author(s): Jack A. Kastelik*Mahmoud Loubani
Affiliation:
- Academic Department of Respiratory Medicine, Hull and East Yorkshire Hospitals NHS Trust, University of Hull and Hull York Medical School, Castle Hill Hospital, Castle Road, Cottingham, East Yorkshire HU16 5JQ,United Kingdom
Keywords: Cardio-respiratory, endobronchial, epidemiology, pathophysiology, pneumothorax, surgical management.
Abstract: Background: Pneumothorax occurs when air enters the pleural cavity. Pneumothorax can be generally sub-divided into spontaneous and non-spontaneous subtypes. The most common examples of non-spontaneous pneumothorax include iatrogenic and traumatic.
Methods: Current studies provide good evidence of epidemiology of this condition. Similarly, there have been improvements in our understanding of underlying mechanisms of spontaneous pneumothorax. In the recent years new approaches to manage patients with pneumothorax have been proposed. These were led by development of new devices as well as better evidence from clinical studies on how to manage pneumothorax.
Conclusions: In this review we will discuss recent developments in our understanding in relation to in epidemiology, pathophysiology as well as management of pneumothorax.
Export Options
About this article
Cite this article as:
Kastelik A. Jack*, Loubani Mahmoud , State of the Art in Medical and Surgical Management of Pneumothorax, Current Respiratory Medicine Reviews 2017; 13 (4) . https://dx.doi.org/10.2174/1573398X14666180312122206
DOI https://dx.doi.org/10.2174/1573398X14666180312122206 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
Call for Papers in Thematic Issues
Exposure to PM2.5 components is associated with respiratory diseases
Through continuous research on the relationship between risk factors and health, it has been found that air pollution, especially atmospheric particulate matter pollution, has become one of the main sources of global disease burden. From 1990 to 2022, the concentration of atmospheric particulate matter pollution has increased by more than ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Toll-Like Receptors and Kidney Diseases
Inflammation & Allergy - Drug Targets (Discontinued) Development of Proteinase-Activated Receptor 1 Antagonists as Therapeutic Agents for Thrombosis, Restenosis and Inflammatory Diseases
Current Pharmaceutical Design Pharmacologic Therapy for Cardiovascular Risk Reduction in Patients with the Metabolic Syndrome
Current Pharmaceutical Design Computational Studies of Competitive Inhibitors of Nitric Oxide Synthase (NOS) Enzymes: Towards the Development of Powerful and Isoform-Selective Inhibitors
Current Medicinal Chemistry TakoTsubo Cardiomyopathy A Short Review
Current Cardiology Reviews Synthesis, Characterization and Physico-chemical Properties of New 2-(4- Arylpiperazine-1-yl)-1-(3-methylbenzofuran-2-yl)ethanoles as Potential Antihypertensive Agents
Current Organic Chemistry A Review of the Diagnostic Scope of Biomarker Techniques, Genetic Screening and Virtual Scanning
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Evolving Novel Chemical Entities for Management of Benign Prostatic Hyperplasia#
Mini-Reviews in Medicinal Chemistry Advances in the Development of Bradykinin Receptor Ligands
Current Topics in Medicinal Chemistry Weight Loss in Obesity and Metabolic Syndrome
Current Hypertension Reviews Concise Review of the Rationale for Pulmonary Embolism Treatment and Endovascular Device Therapies
Current Cardiology Reviews Cardioprotective Peptides from Marine Sources
Current Protein & Peptide Science Editorial [Hot Topic:Applications of Angiotensin Converting Enzyme Inhibitors and of Angiotensin II Receptor Blockers in Pharmacology and Therapy: An Update (Executive Editor: Agostino Molteni)]
Current Pharmaceutical Design Interaction Between KATP-Channels and Protein Kinase C in the Regulation of Basal Coronary Flow
Vascular Disease Prevention (Discontinued) Sarcolemmal K<sub>ATP</sub> Channel Modulators and Cardiac Arrhythmias
Current Medicinal Chemistry Pharmacological Treatment of ADHD and the Short and Long Term Effects on Sleep
Current Pharmaceutical Design Iridoids Analysis by Different Analytical Techniques and its Role as Pharmacologic Agents: A Review
Current Bioactive Compounds Psoriatic Arthritis – Review of the Immunologic, Clinic and Therapeutic Aspects of an Inflammatory Systemic Disease
Current Rheumatology Reviews Introduction to the Special Issue “Pharmacotherapies for the Treatment of Alcohol Abuse and Dependence” and a Summary of Patents Targeting other Neurotransmitter Systems
Recent Patents on CNS Drug Discovery (Discontinued) Targeted Cancer Therapy: The Next Generation of Cancer Treatment
Current Drug Discovery Technologies